Longeveron Inc. (NASDAQ: LGVN) Stock Soars on Clinical Pipeline and 2024 Key Priorities and Goals
April 8, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines is one of NASDAQ’s top gainers today and…